G

GeoVax Labs
D

GOVX

2.94000
USD
0.24
(8.89%)
مغلق
حجم التداول
17,344
الربح لكل سهم
-6
العائد الربحي
-
P/E
-0
حجم السوق
27,742,043
الأخبار

العنوان: GeoVax Labs

القطاع: Healthcare
الصناعة: Biotechnology
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing humanclinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.